India’s Drug Watchdog DCGI Speeds Up Regulatory Overhaul; Single Window Clearance to Precede Central Drug Authority
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's drug regulatory body, the Drug Controller General of India, is set for a comprehensive overhaul of its regulatory and administrative functions